Follow the 지노믹트리 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 지노믹트리 has published 1 public disclosures. Market capitalisation: €265.6bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: 지노믹트리. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Genomictree is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing genomic-based diagnostic solutions.